Angina Prevalence and Provider Evaluation of Angina Relief
NCT01705054 is an observational study sponsored by Saint Luke's Health System. As of 21 Nov 2026, it is completed. It studies Stable Coronary Artery Disease CAD. The registry lists an enrollment of 1,246 participants at 1 site in 1 country. The registry lists a start date of 31 Jul 2013 and a primary completion date of 31 Jul 2015. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01705054 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Saint Luke's Health System |
| Enrollment | 1,246 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Stable Coronary Artery Disease CAD |
| Start | 31 Jul 2013 |
| Primary completion | 31 Jul 2015 |
| Study completion | 22 Jul 2015 |
| Last update posted | 19 Oct 2021 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Faraz Kureshi, MD
St. Luke's Hospital, Kansas City, Missouri
Principal Investigator - John A Spertus, MD, MPH
St. Luke's Hospital, Kansas City, Missouri
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Luke's Hospital of Kansas City
Kansas City
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01705054
Each answer restates registry values shown on this page.
What is NCT01705054?
NCT01705054 is an observational study sponsored by Saint Luke's Health System. It studies Stable Coronary Artery Disease CAD.
Who leads NCT01705054?
The registry names Faraz Kureshi, MD (principal investigator, St. Luke's Hospital, Kansas City, Missouri) and John A Spertus, MD, MPH (principal investigator, St. Luke's Hospital, Kansas City, Missouri) as overall officials.
Where does NCT01705054 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT01705054 end?
The registry lists a primary completion date of 31 Jul 2015 and a study completion date of 22 Jul 2015. The sponsor last updated the record on 19 Oct 2021.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.